Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.

被引：0
|
作者：
Kulp, KS
Green, SL
Vulliet, PR
机构：
[1] UNIV CALIF DAVIS,SCH VET MED,DEPT MOL BIOSCI,DAVIS,CA 95616
[2] STANFORD UNIV,DEPT COMPARAT MED,PALO ALTO,CA 94305
来源：
MOLECULAR BIOLOGY OF THE CELL | 1996年 / 7卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2135 / 2135
页数：1
相关论文
共 50 条
  • [41] Ratio of cyclin-dependent kinase 1 (CDK1) activity to CDK2 activity after ex vivo paclitaxel treatment predicts response to paclitaxel in human breast cancer
    Kim, S. J.
    Taguchi, T.
    Tamaki, Y.
    Tsukamoto, F.
    Akazawa, K.
    Ueno, N. T.
    Hortobagyi, G. N.
    Nakayama, S.
    Torikoshi, Y.
    Gohda, K.
    Ishihara, H.
    Noguchi, S.
    CANCER RESEARCH, 2009, 69 (02) : 366S - 366S
  • [42] A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells
    Zheng, YL
    Li, BS
    Amin, ND
    Albers, W
    Pant, HC
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (18): : 4427 - 4434
  • [43] MIMOSINE, A REVERSIBLE G1/S PHASE-BOUNDARY CELL-CYCLE INHIBITOR, DECREASES P34CDC2/P58CYCLIN A PROLINE-DIRECTED PROTEIN-KINASE ACTIVITY IN MDA-MB-453 BREAST-CANCER CELLS
    KULP, KS
    BERARDI, CJ
    VULLIET, PR
    FASEB JOURNAL, 1992, 6 (05): : A1933 - A1933
  • [44] Cyclin-dependent kinase 2 activity regulates Cdc25A protein levels in human tumor cells independent of p21
    Ducruet, AP
    Lazo, JS
    FASEB JOURNAL, 2004, 18 (04): : A224 - A224
  • [45] Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) beyond progression in hormone receptor positive advanced breast cancer: a systematic review and meta-analysis
    Pathak, Neha
    Kumar, Sudhir
    Gimenez, Diego Malon
    Di Iorio, Massimo
    Valiente, Consolacion Molto
    Cuthbert, Danielle
    Li, Meredith
    Batra, Atul
    Nadler, Michelle
    Amir, Eitan
    Mittal, Abhenil
    CANCER RESEARCH, 2024, 84 (09)
  • [46] Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) plus endocrine therapy (ET) treatment in metastatic lobular breast cancer (mLBC): A retrospective cohort study
    von Arx, C.
    Calabrese, A.
    Martinelli, C.
    Di Lauro, V.
    Grimaldi, V.
    Pensabene, M.
    Caputo, R.
    Cerillo, I.
    Cianniello, D.
    Buono, G.
    Verrazzo, A.
    Pacilio, C.
    Di Rella, F.
    Nuzzo, F.
    De laurentiis, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S370 - S370
  • [47] Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex
    Garcia, HH
    Brar, GA
    Nguyen, DHH
    Bjeldanes, LF
    Firestone, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) : 8756 - 8764
  • [48] Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
    Barhoover, Melissa A.
    Hall, Julie M.
    Greenlee, William F.
    Thomas, Russell S.
    MOLECULAR PHARMACOLOGY, 2010, 77 (02) : 195 - 201
  • [49] INTERFERON-ALPHA INHIBITS CYCLIN E-DEPENDENT AND CYCLIN D1-DEPENDENT CDK-2 KINASE-ACTIVITY ASSOCIATED WITH RB PROTEIN AND E2F IN DAUDI CELLS
    ZHANG, KR
    KUMAR, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) : 522 - 528
  • [50] Growth Inhibition of Human MDA-MB-231 Breast Cancer Cells by δ-Tocotrienol Is Associated with Loss 9 of Cyclin D1/CDK4 Expression and Accompanying Changes in the State of Phosphorylation of the Retinoblastoma Tumor Suppressor Gene Product
    Elangovan, Selvakumar
    Hsieh, Tze-Chen
    Wu, Joseph M.
    ANTICANCER RESEARCH, 2008, 28 (5A) : 2641 - 2647
12345